Close

Sign in
Sign up

Menu

Intel
Data search
Signals
Startup Concierge
Get intel

Home
News
Agomab raised $40.5 million in Series B extension funding led by Pfizer, and joined by Walleye Capital and Asabys Partners

Agomab raised $40.5 million in Series B extension funding led by Pfizer, and joined by Walleye Capital and Asabys Partners

Biotech Health services

Belgium

Spain

United States

Investments

08 July 2022

Share:

Agomab (company)

Belgium

Biotech Health services

Total investments received (USD): 303.5m

Round value (USD): 40.5m

Round investors: Asabys Partners Pfizer Venture Investments Walleye Capital

Company: Agomab

Industry: Biotech Health services

Related deals

AstriVax raises a €30 million seed round led by V-Bio Ventures and Fund+

Biotech Health services Pharma

Belgium

France

Netherlands

Investments 22 August 2022

eTheRNA raised €39m in Series B2 funding from Kenneth Chien, Marijn Dekkers and insiders LSP, PMV, Grand Pharma, Fund+ and Omega Fund

Biotech Health services

Belgium

Netherlands

United States

China

Investments 19 August 2022

Sidebar

Verticals

Financial Services
Food Industry
Education
E-commerce
Health services
Marketplace

Benelux

Belgium
Netherlands

DACH

Austria
Germany
Switzerland

Nordics and Baltics

Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden

Western Europe

France
Ireland
Italy
Portugal
Spain
United Kingdom

About
Contact
Terms of service
Privacy policy

© All rights reserved Nordic 9 2016-2026. Made with in Stockholm

Top